What to expect: Switch from daily liraglutide to weekly semaglutide. Different molecule but same GLP-1 class. Restart titration from Wegovy 0.25 mg. Saxenda clears quickly (13-hour half-life).
Washout window: ~2 days for Saxenda to clear
Why patients switch from Saxenda to Wegovy
- Daily injection burden — Wegovy is weekly
- Greater weight-loss efficacy — STEP-1 (~15%) vs SCALE (~8%)
- Insurance shifted to cover Wegovy preferentially
- Saxenda discontinuation announced by Novo Nordisk for some markets
- Patient preference for less-frequent dosing
Side effects during the Saxenda → Wegovy transition
- Mild GI upset during titration restart
- Adjustment to weekly vs daily dosing rhythm
- Brief 1-2 lb weight fluctuation
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — confirm obesity indication eligibility
- If pediatric (Saxenda labeled 12+; Wegovy labeled 12+ as of 2022)
Dose conversion: Saxenda → Wegovy
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Saxenda dose | Wegovy dose | Note |
|---|---|---|
| Any | Restart titration from lowest dose | Different mechanism (liraglutide → semaglutide). No direct conversion. |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (liraglutide → semaglutide), insurance implications.
Week −1: Last Saxenda dose
Continue your current Saxenda schedule. Saxenda has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Wegovy dose
Restart titration from lowest Wegovy dose. Overlap effect possible in the first 7-10 days as Saxenda clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. Adjust to new effect onset timing. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Saxenda baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Saxenda, discuss reverting or trying a third option (often tirzepatide-based).
FAQ — Saxenda → Wegovy
Can I take Saxenda and Wegovy together?
No. Combining GLP-1 medications isn't done outside clinical trials. Stop Saxenda before starting Wegovy; the long half-lives mean overlap occurs naturally.
Will I lose ground when switching from Saxenda to Wegovy?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Saxenda efficacy. Plan and 12-week evaluation window.
Does insurance cover Wegovy if it covered Saxenda?
Different molecule means different formulary placement. Run a fresh prior authorization for Wegovy — coverage of Saxenda doesn't transfer automatically.
How long does Saxenda stay in my system after the last dose?
Liraglutide has a 13-hour half-life — effects clear in 2-3 days. Daily dosing means transitions are quicker.
Cost comparison
Cash-pay pricing differs significantly between Saxenda and Wegovy. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Wegovy
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Wegovy availability, price, and prescriber accessibility.
See top Wegovy providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Saxenda review and Wegovy review. For provider options that carry both medications, see our Saxenda vs Wegovy comparison and Saxenda alternatives hub.
Sources
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.